EFFECT OF YASADA BHASMA ON ORAL SODIUM PHOSPHATE INDUCED NEPHROCALCINOSIS IN RATS
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2011, Vol 2, Issue 1
Abstract
Nephrocalcinosis is a condition characterized by calcium salt deposits in the kidneys which may affect it's ability to function. Nephrocalcinosis is caused by a number of conditions including: the excess excretion of calcium by the kidney, renal tubular acidosis, medullary sponge kidney, hypercalcemia (high calcium levels in the blood), renal cortical necrosis, and tuberculosis. Nephrocalcinosis is relatively common in premature infants, partly from intrinsic kidney calcium losses and partly from enhanced calcium excretion when they are given diuretics. In the present study, nephrocalcinosis was induced in an animal model by administrating sodium phosphate (4100mg/kgbw) orally and the nephrotoxic rats were treated with Yasada Bhasma, a herbo mineral preparation at different doses. The levels of Alkaline Phosphatase, Acid Phosphatase and calcium were analysed in order to determine preventive effect of Yasada Bhasma. The kidney function was also assessed by determinig the serum levels of urea, uric acid and Creatinine. The histopathology of kidney was also carried out to support the nephroprotective effect of Yasada Bhasma. Impaired kidney function was observed in rats with sodium phosphate induced nephrocalcinosis followed by acute renal failure. The levels of blood urea, serum creatinine and phosphorous were increased significantly in sodium phosphate induced nephrocalcinosis. The oral administration of Yasada bhasma produced the most significant reduction in the levels of blood urea, serum creatinine and phosphorous. Acute kidney injury is an important risk factor for urolithiasis and nephrocalcinosis in Oral Sodium Phosphate ingestion, and can coexist with hypercalciuria. A novel type of an ayurvedic drug (Yasada Bhasma) was produced which has high potentials for inhibition and prevention of nephrocalcinosis in Oral Sodium Phosphate treatment. Finally, studies in the mechanism of action of Yasada Bhasma and the product development as well as safety evaluation of the standard herbal extract are definitely required for future pharmacological applications of Yasada Bhasma as nephroprotective drug for Oral Sodium Phosphate induced nephritis.
Authors and Affiliations
Arul John Agnel , P. Brindha
Keywords
Related Articles
- EP ID EP97701
- DOI -
- Views 88
- Downloads 0
PHARMACOGNOSTIC PARAMETERS AND PHYTOCHEMICAL SCREENING OF CONVOLVULUS ARVENSIS LINN.
In this study the aerial parts of Convolvulus arvensis Linn. (Convolvulaceae) were collected and identified. Various Pharmacognostic parameters needed for evaluation are performed, which might be helpful in herbal medic...
DEVELOPMENT AND VALIDATION OF RP-HPLC ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF PHENTERMINE AND TOPIRAMATE IN PURE AND ITS PHARMACEUTICAL DOSAGE FORMS
Developing a single analytical method for estimation of individual drug from a multidrug composition is a very challenging task. A simple, rapid, precise, and reliable simultaneous stability indicating RP - HPLC method...
ULTRADEFORMABLE LIPID VESICLE AS A NOVEL DRUG DELIVERY SYSTEM
Various new technologies have been developed for the transdermal delivery of some important drugs. Transdermal route will always remain a lucrative area for drug delivery.The transdermal route of drug delivery has gained...
ENHANCING SOLUBILITY AND DISSOLUTION OF INDOMETHACIN BY FREEZE DRYING
Indomethacin, an anti-inflammatory drug, exhibits poor water solubility and flow properties. Freeze dried crystals were prepared by freeze drying method. Solvent composition for freeze drying chosen were isopropyl 10 ml...
PRO-CHOLINERGIC, HYPO-CHOLESTEROLEMIC AND MEMORY IMPROVING EFFECTS OF CLOVE
Clove is found to possess useful medicinal properties, such as anti-microbial, anti-inflammatory, anti-diabetic and anti-oxidant. The present study was undertaken to investigate the effects of Syzygium aromaticum (Clove)...